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Human hepatocellular carcinoma (HCC) is one of the most
common types of tumour, especially in Asia and Africa (Anderson
et al, 1992; Okuda, 1992; Parkin et al, 1993). HCC is characterized
by extensive carcinoma cell infiltration and metastasis. Although
advances have been made in liver cancer therapies, most cancer
deaths still result from metastatic disease, so metastasis has been
the greatest obstacle to successful tumour treatment. The poor
understanding of the molecular mechanisms responsible for the
disseminated metastasis, which would be partly due to the lack of
ideal samples and models for study, has hindered the development
of effective antimetastatic therapies. Although several reports of
the establishment of HCC cell lines were available (Chen, 1963;
Alexander et al, 1976; Dong et al, 1980), none have demonstrated
prominent metastatic potential. The human cell line with a
metastatic potential from primary tumour or metastatic lesions
would permit metastatic mechanisms to be studied further.
However, the cancer cells from the surgical samples or metastatic
lesions can only be maintained in primary culture for a short time
before cellular senescence occurs. The aim of this study was to
establish a human HCC cell line with a metastatic potential. We
successfully established a new HCC cell line with a highly
metastatic potential derived from subcutaneous xenograft of a
metastatic model of human HCC in nude mice (LCI-D20) (Sun et
al, 1996) by improving the conventional method of establishing a
cell line – alternating cell culture in vivo and growth in nude mice.
In this paper the processes of establishing a new human HCC cell
line MHCC97 and some characteristics, including observation of
some factors associated with metastasis, are reported.
MATERIALS AND METHODS
Specimens and in vitro culture
Seventy-eight primary cultures were taken from subcutaneous
or intrahepatic xenografts of LCI-D20 nude mouse models. The
model was developed by orthotopic inoculation of an intact
tumour tissue of an intrahepatic disseminated lesion from a 39-
year-old Chinese male patient with HCC (Zhong-Shan Hospital,
Shanghai Medical University). Abnormal alpha-fetoprotein (AFP)
and HBsAg were found in serum from this patient. The LCI-D20
model represents 100% metastases to the lungs, lymph nodes and
intrahepatic spreading (Sun, 1996).
These xenografts were removed and used for primary culture in
vitro by different culture methods (tissue fragments or single-cell
New human hepatocellular carcinoma (HCC) cell line
with highly metastatic potential (MHCC97) and its
expressions of the factors associated with metastasis
J Tian, ZY Tang, SL Ye, YK Liu, ZY Lin, J Chen and Q Xue
Liver Cancer Institute and Zhong-Shan Hospital, Shanghai Medical University, Shanghai 200032, Peoples Republic of China
Summary A new human hepatocellular carcinoma (HCC) cell line with a highly metastatic potential was established from subcutaneous
xenograft of a metastatic model of human HCC in nude mice (LCI-D20) by means of alternating cell culture in vitro and growth in nude mice.
The line, designated MHCC97, has been cultivated for 18 months and subcultured for more than 90 passages. The line was showed to be of
human origin by karyotype analysis. The cells were either grown as compact colonies (in clusters) or as a monolayered sheet with about
31 h of population-doubling time, exhibited typical malignant epithelial in morphology and were positive for a-fetoprotein (AFP). Flow
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abnormalities in number and structure. The number of cell line MHCC97 chromosome ranged from 59 to 65 with a modal number of 60 and
61. At least two common chromosome markers, i(1q) and der(4)t(4;?)(4pter®q35::?), were present in all cells, and deletion of Y chromosome
also occurred in all cells. The subcutaneous and intrahepatic xenografts were formed and metastatic lesions in lungs were found after the
cells were inoculated into nude mice. The rate of metastasis to lungs was 100% using orthotopic inoculation. Reverse transcription
polymerase chain reaction products revealed positive expressions of integrin a5 and b1, urokinase type plasminogen activator receptor
(uPAR), vascular endothelial growth factor and nm23-H1 mRNAs of cell line MHCC97. Immunostaining of c-Met, uPAR showed strongly
positive in both subcutaneous xenografts and lung metastatic lesions; while positive in xenografts and negative in metastatic lesions for
integrin a5, b1. E-cadherin and P53 was not expressed either in xenograft or in the metastatic lesions. PCR products of HBsAg and HBxAg
were both positive. The cell line MHCC97 still retained some characteristic features of original tumour. Establishment of cell line MHCC97
should be beneficial to the studies of HCC metastatic mechanisms. © 1999 Cancer Research Campaign
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E-mail: jtian@som.llu.edususpension). Different culture mediums (RPMI-1640, Dulbecco’s
modified Eagle’s medium (DMEM) or DMEM/RPMI-1640;
Gibco-BRL) with fetal calf serum (FCS; Gibco-BRL), newly born
serum (NBS; Shanghai Institute of Cell Biology, Academiae
Sinica) or human blood group AB serum (purchased from the
Blood Center, Shanghai) were employed. Briefly, about ten 1–
2m m 2 fragments were transferred to a 25-cm2 plastic culture flask
(Nunclon™, Denmark) with RPMI-1640 or DMEM containing
10% of one kind of serum above. The medium containing single-
cell suspension obtained by tearing xenograft in serum-free
DMEM was transferred to a 10-ml centrifuge tube and allowed to
stand undisturbed for about 5–10 min until the small pieces of
tissue and clusters of cell settled at the bottom of the tube. The
suspension with dispersed cells was aspirated into another tube
and centrifuged slightly. The pellet was washed once in medium
by light centrifugation. Cells were resuspended with DMEM
supplemented with 10% heated-inactivated human blood group
AB serum without antibiotics and seeded into 25-cm2 plastic
culture flasks (Nunclon™, Denmark) at 37°C in a humidified
atmosphere with 5% carbon dioxide. Twenty-four hours after
seeding, the cultures were washed in DMEM and fed with fresh
complete medium; the medium was routinely changed every 2–3
days. At confluence the cells were subcultured by exposure to
trypsin–versene (0.25% trypsin with 0.02% EDTA) in a calcium
ion (Ca2+) and magnesium ion (Mg2+)-free Hank’s solution. In
order to ensure tumour cells for long-term culture in vitro, we
developed a new culture method by modifying conventional
method of establishing cell line. Briefly, after cultured for 1.5
months or subcultured 5–7 passages before cellular senescence
occurred, the cells (³ 106) were returned to the subcutis of nude
mice (BALB/c) until tumour nodules formed and then were re-
treated as above. This procedure was repeated 5–6 times. The
cancer cells treated in this way could grow steadily and be subcul-
tured successfully in vitro. The 33258 Hoechst stain was routinely
employed for Mycoplasma testing.
Determination of doubling time
The cells of passage 40 were studied to estimate the population-
doubling time. The initial cell number was 4 ´ 104 cells well–1 in
triplicate in 24-well plate (Nunclon, USA). A cell count was taken
every 2 days in three wells, and the growth medium was changed
every 2 days. The number of viable cells was determined in a
haemocytometer every 48 h for 20 days by trypan blue staining.
The doubling time of the cell line MHCC97 was calculated during
the exponential growth phases.
Morphology and ultrastructure of the MHCC97 cell line
Cells in flasks were photographed directly without stain under 
the phase-microscope. For electron microscopic analysis, the
monolayer cells were scraped from flasks and pelleted. The pellet
was fixed with 2.5% glutaraldehyde in 0.1 mol phosphate-
buttered saline (PBS), pH 7.2, washed in 0.1 mol PBS, and then
post-fixed in 2% osmium tetraoxide after dehydration in ethanol;
then the samples were embedded in Epon resin. Ultrathin
sections were stained with uranyl acetate and lead citrate, and
examined under a JEOL 1200EX (JEOL, Tokyo, Japan) electron
microscope.
Histology of xenografts
Routine histology was carried out in order to compare morphology
of original xenografts with that of tumour xenografts developed
after re-inoculation of cultured MHCC97 cells. The subcutaneous
and intrahepatic xenografts were fixed in 10% neutral formalin,
processed routinely, and paraffin sections stained with haema-
toxylin and eosin (H&E).
Measurement of DNA content by flow cytometry
DNA content of nuclei from cultured cells at the 30th passage
was analysed by flow cytometry. In brief, cultured cells were
trypsinized and the resulting suspension transferred to a 10-ml
centrifuge tube for centrifugation, resuspended in 10 ml PBS and
pelleted once before being resuspended in citrate buffer. A total
of 1 ´ 106 cells was treated with 1.8 ml of trypsin, and then
propidium iodide (0.25 mg ml–1), ribonuclease (5 mg ml–1) and
Triton X-100 (1%) were added for more than 15 min prior to
analysis. Cells were analysed using a FACScan machine (Becton-
Dickinson). The DNA index was calculated relative to normal
adult peripheral blood lymphocytes.
Cytogenetic analysis
Chromosome preparation and G-banding were performed as
Seabright (1971) described, but slightly modified. Briefly, colcemid
was added to cell cultures at the 35th passage to a final concentration
of 0.25 mg ml–1 for 10–15 h. The cells were then trypsinized and
centrifuged at 1200 rpm for 12 min. The hypotonic medium used
was 0.075 mol potassium chloride for 20 min at 37°C, and then the
fixative (methanol:glacial acetic acid, 3:1) was changed three times
before slides were made. Some of the slides were aged at 60°C for
8–10 h for G-banding. The aged slides were trypsinized for 3.5 min,
rinsed in water and stained with Giemsa, rinsed again, air dried and
examined under microscope. The rest for C-banding was soaked in
0.2 N hydrochloric acid for 1 h, and then incubated in 5% Ba(OH)2
at 56°C for 10 min and rinsed in water. After that, the slides were
re-incubated with 2 ´ SSC (standard saline citrate) at 67°C for
1–1.5 h, rinsed again and stained with Giemsa.
Tumorigenicity and metastasis assays in nude mice
Cultured cells at the 5th, 15th, 20th, and 35th passages were
washed with Ca2+ and Mg2+-free Hank’s solution, and 0.1–0.2 ml
of a cell suspension (> 1 ´ 106) was injected into the livers,
subcutises or eyes of 16 weanling athymic nude mice (BALB/c
nu/nu) respectively for tumorigenicity and spontaneous metastasis
assay. The mice housed in microisolator cages under specific
pathogen-free conditions, and were fed autoclaved pellets. Tumour
formation was monitored every 2 days before sacrificed. The
developed subcutaneous xenografts were then re-inoculated into
mouse livers for spontaneous metastasis assay or eyes for tumori-
genicity. All animals inoculated intrahepatically were sacrificed
for metastatic assay when they appeared distressed after the initial
injection of cells. For each assay, major organs (lung, liver, spleen,
kidney, stomach, colon, brain and lymph nodes) were examined
for the presence of metastases. Above organs were removed after
inoculation for 35 days and fixed in 10% neutral formalin for
paraffin-embedded sections and H&E staining. The metastatic
focuses were evaluated under light microscope.
Establishment of a metastatic cell line of HCC 815
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Immunohistochemical procedure
The intrahepatic xenografts developed and lungs from the nude
mice inoculated with MHCC97 cells were removed and fixed in
10% neutral formalin. The paraffin-embedded sections and the
cells grown on coverslips were stained by the avidin–biotin–
peroxidase complex (ABC) method.
Briefly, after deparaffinizing and hydrating, these tissue sections
and cells on coverslips were first soaked in methanol containing
0.6% hydrogen peroxide for 30 min to block endogenous peroxi-
dase activity. They were then treated with 10% normal blocking
serum at 37°C for 30 min to suppress non-specific stain in humid-
ified chamber. Suction was used to remove reagents after each
step, but the drying of specimens between two steps was avoided.
After that, they were washed in PBS, and then incubated with
individual primary antibody for 1 h at 37°C and overnight at 4°C.
Then sections were re-incubated with biotinylated second-step
antibodies for 1 h at 37°C and avidin–biotin enzyme reagent for
30 min respectively. Finally, sections were rinsed in 0.5% Triton
X-100/PBS prior to chromogenesis with a 3,3¢-diamobenzidine
tetrahydrochloride and hydrogen peroxide mixture. Haematoxylin
was used as a counterstain. Primary antibodies were used as
follows: rabbit anti-human AFP polyclonal antibody (Dako,
Denmark), murine anti-human integrin a5 and b1 subunit mono-
clonal anti-serum (from the Department of Biochemistry,
Shanghai Medical University), goat anti-human E-cadherin poly-
clonal antibody (Santa Cruz Biotechnology, Inc.) and rabbit anti-
human uPAR (from the Department of Molecular Biology,
Shanghai Medical University) and c-Met (Santa Cruz Bio-
technology, Inc.) polyclonal antibody and P53 respectively.
Negative controls were included in each test by substitution
normal animal serum for primary antibodies.
PCR analysis of HBV-DNA
Polymerase chain reaction (PCR) analyses were performed with
HBsAg, HBcAg and HBxAg primers.
DNA isolation
A total of 1 ´ 106 cultured cells were thoroughly homogenated in
400 ml DNA denature solution, following incubated in 100 ml 10 ´
SDS, 20 ml RNAase, 20 ml proteinase K at 37°C for 24 h. The
DNA was extracted with phenol–chloroform. Extracted DNA was
precipitated with ethanol, and resuspended in distilled water.
PCR procedure
The DNA template of HBsAg, HBcAg and HBxAg primers was
PCR-amplified by adding 10 ml of DNA to 50 ml final volume
PCR mixture containing 3 ml of 25 mmol potassium chloride, 5 ml
of 10 ´ amplification buffer, 1 ml of 20 mmol dNTP, 2 ml of
50 pmol HBsAg, HBcAg and HBxAg primers, and 2 units of Taq
DNA polymerase (Promega). The complete denaturation of the
DNA template was carried out at 94°C for 4 min prior to the start
of PCR reaction. Thirty-five cycles were performed at 94°C for
1 min, 55°C for 1 min and 72°C for 1 min. The samples were 
re-incubated at 72°C for 7 min after cycles finished. The PCR
products were separated by electrophoresis on a 1.2% agarose-
TAE (Tris acetate buffer) and stained with ethidium bromide.
Reverse transcription (PCR)
Total cellular RNA prepared from 1 ´ 106 cells using Qiagen
RNeasy Mini Kit (QIAGEN, Germany). The procedure was
performed according to the protocol provided by the manufacturer.
Total RNA (5 mg) extracted from cell line MHCC97 was used as a
template for synthesis of oligo(dT)15-primed double-stranded
cDNA using SuperScript™II RNAase H– Reverse Transcriptase
(Life Technologies, Inc.). The reaction was terminated by heating at
94°C for 4 min to inactivate reverse transcription (RT) prior to the
start of PCR and then 35 cycles were performed at 94°C for 1 min,
annealing temperature (shown in Table 1) for 1 min, and primer
extension at 72°C for 1 min. The samples were re-incubated at
72°C for 7 min after the cycles finished. The amplified products
were separated by electrophoresis on a 1.2% agarose gel in Tris
acetate buffer and stained using 1 mg ml–1 ethidium bromide.
RESULTS
Establishment of a cell line
The 78 cultures derived from subcutaneous or intrahepatic xeno-
grafts of LCI-D20 model were used in an attempt to establish a
metastatic cell line of human HCC. At last, only one, which derived
from subcutaneous xenograft and was incubated in DMEM with
high glucose and 10% human blood group AB serum, could be
maintained and subcultured in vitro by a modified culture method
of establishing a cell line – alternating cell culture in vitro and
growth in nude mice. At the time of this report, the line had contin-
uously grown for 18 months in vitro and discontinuously for more
than 2 years, including the period of growth in nude mice.
Table 1 Oligonucleotide primer sequences used for cDNA amplification
Factor Primer Primer sequence Annealing Product
(°C) (bp)
Integrin a5 Sense 5¢-ACCAAGGCCCCAGCTCCATTAG-3¢ 57 357
Antisense 5¢-GCCTCACACTGCAGGCTAAATG-3¢
Integrin b1 Sense 5¢-AACTTGATCCCTAAGTCAGCAGTAG-3¢ 57 1200
Antisense 5¢-ATCAGCAGTAATGCAAGGCC-3¢
uPAR Sense 5¢-GCTTAGAGAAGACGTGCAGGGA-3¢ 55 454
Antisense 5¢-TTCACCTTCCTGGATCCAGT-3¢
VEGF Sense 5¢-TTGCTTGCTCTACCTCCAC-3¢ 55 490
Antisense 5¢-AATGCTTTCTCCGCTCTG-3¢
nm23-H1 Sense 5¢-GCAGCCGGAGTTCAAACCTAA-3¢ 61 585
Antisense 5¢-GCTGGGAGGAAGCATTTTAATC-3¢Establishment of a metastatic cell line of HCC 817
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Morphology and growth pattern of MHCC97 cell line
During the first 3 weeks of the primary culture, proliferating
tumour cells formed small colonies, some of which were
surrounded by a fair number of fibroblasts. However, these fibrob-
lasts gradually faded as subcultures were carried out. The cell line
MHCC97 was either grown in clusters with contact inhibition loss
or as monolayer polygon with clear boundaries (Figure 1). The
cells were characterized by an epithelial-like shape with prominent
nuclei. Ultrastructurally, most individual cells revealed large ratio
of prominent irregular nuclei with deeply identified nuclear
membrane relative to cytoplasm. More euchromatin and myeli-
noid bodies, swollen mitochondria, granular glycogen were
frequently visible in MHCC97 cells. Many and long microvilli on
the cell surface but few junctions were seen (Figure 2). The line
grew free of Mycoplasma contamination and showed doubling
time of 31 h.
Histology of xenografts
MHCC97 cells were implanted subcutaneously and intrahepati-
cally in nude mice. The resultant tumours closely resembled the
original xenograft maintained in nude mice in histology. The
xenograft tissues were characterized by a typical pathology of
hepatocellular carcinoma. The tumour cells arranged in a nest with
few mesenchymes. Most of the tumour cells had large multinuclei
with the nuclear membrane showing deep indentation. The
multi–nucleated giant cells were often seen. Pathologically, the
cancer cell of metastatic lesions in lungs were also demonstrated
to have a characterization of HCC (Figure 3).
Profile of DNA content
Analysis of DNA content from the cell line MHCC97 by flow
cytometry indicated that the samples contained a major aneuploid
population, with approximately 1.5 times more cells compared to
that of normal human peripheral blood lymphocytes.
Karyotype analyses of cell line MHCC97
Karyotype analyses revealed only human chromosomes with gross
aneuploidy. G-banding technique showed the presence of chromo-
some abnormalities in number and structure in all the cells exam-
ined. The number of cell line MHCC97 chromosome ranged from
59 to 65 with a modal distribution at 60 and 61. The monosomies
13, 14 and 15 also appeared in all the cells. At least two distinctive
marker chromosomes, i(1q) and der(4)t(4;?)(4pter®q35::?), were
invariably present in all the cells (Figure 4), and the intact Y chro-
mosome was absent in all the cells by G- and C-banding analyses.
However, a narrow, deeply stained band inserted in the long arm of
chromosome group B was noted in a few cells in C-banding
karyotypes. The positive results of PCR-amplified product for
DYZ-1 primer of Y chromosome may indicate that this inserted
band derived from Yqh. In addition, other abnormalities, such as
trisomies 5,6,11, polysomies (³ tetrasomies) 7,12 and rearrange-
ments of unidentified chromosomes were present in most of the
cells examined (Tables 2 and 3).
Tumorigenicity and metastatic potential in nude mice
All animals developed solid tumours at subcutis, liver and
eye, with the dispersed cells or intact tissue inoculation.
Tumorigenicity rate was 100%. The tumour nodules usually
became visible or palpable after 15 days, and vessels were
Figure 1 Microphotograph of the cultural cell line MHCC97 (passage 35) Figure 2 Electron microphotographs of MHCC97 cells displaying irregular
nuclei with deeply indented nuclear membrane, myelinoid bodies, swollen
mitochondria in cytoplasm and abundant microvilli on cell surface (´7500)
AB
Figure 3 Microphotographs of pulmonary metastatic lesions from nude
mice with MHCC97 cell inoculations with H&E stain (A) and AFP
immunostain (B) (´400). Scale bar = 25 mm818 J Tian et al
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frequently induced to develop at inoculated sites. These resultant
tumours grew invasively in surrounding  tissues, which resembled
that of the original xenograft. All autopsies, covering the lung,
liver, kidney, spleen, brain, stomach and bowel, were examined
histologically for metastasis assay. The resultant metastatic lesions
were only found in the liver and lungs. The metastatic rate was
100% with intrahepatic inoculation. There were no prominent,
enlarged lymph nodes found. Strongly positive stain for AFP was
seen in both xenograft and metastatic lesions (Figure 3).
Expression of integrin a5 and b1, uPAR, VEGF and
nm23-H1 mRNAs
RT-PCR was performed on total RNA extracted from cell line
MHCC97 for mRNA expressions of factors associated with
metastasis, such as integrin a5, b1 subunits as the receptors for
fibronection, urokinase type plasminogen activator receptor
(uPAR) indirectely responsible for the degradation of extracellular
matrix (ECM) and VEGF involved in the development of tumour
vessels. All RT-PCR products of the above factors were positive
for MHCC97 cells.
Expression of integrin a5 and b1, uPAR and c-Met
proteins
Immunostaining patterns varied with the antibodies employed.
The strongly positive stains for c-Met and uPAR confined to the
cytoplasm and membrane were present in all cancer cells and
xenografts, pulmonary metastatic lesions from treated nude
mice. Positive results were obtained in some cancer cells of
xenografts, but negative in metastatic lesions for a5, b1. E-cadherin
was not expressed either in xenografts or in metastatic lesions. In
contrast, no positive stain was detected with normal serum (Figure
5).
DISCUSSION
Hepatocellular carcinoma is the most frequent malignancy in
China. Infection of viral hepatitis B remained one of the major
backgrounds of HCC for Chinese patients. The patients often die
from metastasis and recurrence of HCC. Unfortunately, mecha-
nisms with regard to metastasis are not yet fully understood.
The establishment of human cancer cell lines/strains would be
useful in the study of tumour development and progression. For
several technical reasons, the success rate for establishment of
carcinoma cell lines is extremely low, commonly less than 2%
(Park et al, 1990; Amadori et al, 1993; Hambly et al, 1997), espe-
cially for cell lines with metastatic properties.
Krause summarized three factors affecting the success of culture
growth (Krause, 1981). The highest cause of failure is a lack of
adequate viable cells, which are not likely to thrive in vitro. The
overgrowth of promising tumour cells by fibroblasts is another. A
xenograft from an ideal animal model bearing human tumour
would provide more viable cells compared with surgical samples
used directly to establish cell lines. Our institute previously devel-
oped a metastatic model of human HCC in nude mice (LCI-D20)
(Sun et al, 1996), which could provide ideal cancer cells for the
establishment of a metastatic cell line. The establishment of
MHCC97 suggested that the success rate would be higher by
means of repeated combination of culture in vitro and growth in
nude mice than by conventional culture methods; and the
dispersed cells by mechanical isolation would be superior to tissue
fragment for culture. The former may make the cells acquire the
phenotype for long-term culture in vitro and retain or regain
several properties of the original tumour (Tom et al, 1977), such as
AFP synthesis and lung metastasis; and the latter would reduce the
contamination of fibroblasts. In addition, we also found that
human blood group AB serum does not seem to suit for mouse
fibroblast growth.
Based on the biological behaviour, MHCC97 possesses a highly
metastatic potential, and the lungs seem to be the preferential
target organ for its metastasis, which is similar to the patients with
HCC in clinic.
Activation of oncogenes caused by hepatitis virus integration
has been well shown in the woodchuck animal model (Hsu et al,
1988; Fourel et al, 1990). The integration of HBV into genomic
DNA is associated with chromosome changes in recipient cells
MIM2
1 A3 4 B 5 M3
6 C 12
13 D1 5 16 E1 8
19 F 20 21 G 22 XY M4 M5 M6 M7 M8 M9 M10
Figure 4 G-branded karyotype of MHCC97 cell line (passage 35)
Table 2 Appearing frequency of abnormal chromosomes in 22 karyotypes analysed (35th passage)
Extra chromosomes Abnormal chromosomes
(markers)
Chromosome –Y +2 +3 –4 +5 +6 +7´2M 1 M 2 M 3
Frequency 22 14 9 12 9 20 16 15 22 22
Chromosome +11 +12´2 –13 –14 –15 +16 +18 M4 M5 M6
Frequency 15 17 22 22 22 11 11 12 12 14
Chromosome +19 +20 –21´2M 7 M 8
Frequency 9 12 22 15 17
*Appearing frequency of abnormal chromosomes exceeded 50% of karyotypes analysed.Establishment of a metastatic cell line of HCC 819
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(Rogler, 1985). PCR-amplified products of HBsAg and HBxAg
indicate that HBV may have integrated into genetic DNA of cell
line MHCC97, although the line has lived for a long time in vitro.
Chromosome abnormalities are the hallmark of cancer cells.
Cancer is thought to be caused by a series of alterations of a
limited number of specific genes, which reflects cumulative
genetic alteration, including activation of oncogenes and inactiva-
tion or loss of tumour suppressor genes (Bishop, 1991; Weinberg,
1992; Kuroki et al, 1995). Multiple genetic alterations are gener-
ally suggested to be involved in the development of HCC
(Sugimura, 1992), but loss of tumour suppressor genes may be a
more important genetic aberration that is responsible for HCC
formation (Yeh et al, 1996). Karyotypic analysis revealed that
recurring and highly consistent structural and numerical alterna-
tions were present in all the cells examined, corresponding with
the characteristics of malignant tumour in genetics. Large propor-
tions of chromosomal modal (73%) and two chromosome markers
presented invariable in all cells indicated that MHCC97 may be of
monoclonal origin (Liao et al, 1975). Monosomy is known to be
one of the mechanisms of tumour suppressor gene loss in malig-
nant tumours (Bishop, 1991). Kuroki et al (1995) reported that at
least one putative tumour suppressor gene for HCC, other than
retiroblastona, exists on chromosome 13q. Some investigators
have shown that allelic losses on chromosome 13q tend to occur
more frequently in advanced HCC, being apparently associated
with progression of the tumours (Murakami et al, 1991). The
appearance of monosomies 13,14,15 in the line may have implied
that some locus of chromosome contains the putative tumour
suppressor genes or metastasis suppressor genes. Trisomy is also
observed in HCC. The consequences of monosomy and trisomy
may result in the loss of tumour suppressor genes or amplification
of oncogenes by dose effects during development and progression
of tumours.
Any one of several mechanisms, such as point mutation, translo-
cation, amplification, or loss of the whole chromosome or part of a
chromosome, can activate oncogenes or inactivate tumour
suppressor genes and allow a cell to escape from normal control of
growth (Fujimori et al, 1991). From conventional cytogenetics it has
been suggested that chromosome 1 abnormalities are associated
with HCC (Simon et al, 1990, 1991; Bardi et al, 1992; Chen et al,
1993; Werner et al, 1993; Yeh et al, 1994). The most consistent aber-
rations detected concerning chromosome 1 in HCC are polysomy 1
or deletion or translocation involving its short arm (Simon et al,
1990; Bardi et al, 1992; Chen et al, 1993; Yeh et al, 1994).
Chromosome 4q abnormality was also significantly associated with
HCC (Pasquinelli, 1988; Zhang et al, 1990; Yeh et al, 1996). The
strong correlation of LOH at 4q with AFP elevation in HCC
suggests that loss of such putative tumour suppressor genes can also
remove the repression of AFP gene expression (or allow persistent
AFP gene expression) (Yeh et al, 1996). The establishment of the
metastatic line may aid further study of the relation between the
special aberrations of chromosomes and metastasis of HCC.
Invasion and metastasis are the greatest obstacles to successful
tumour treatment. The metastasis is a complex and multistep
process (Aznavoorian et al, 1993; Nigam et al, 1994). For tumour
cells to metastasize, they must acquire the ability to detach from
the primary tumour, and penetrate and exit through the wall of the
vascular and/or lymphatic circulatory system, and undergo the cell
proliferation and angiogenesis required for colonization in a target
organ (Nigam et al, 1994). Gene products that regulate the
processes of cell adhesion, ECM/BM degradation, cell motility,
cell growth and angiogenesis could contribute to the metastatic
potential. Many of these phenotypes have been associated with
adhesive molecules, activation and secretion of proteinases,
motility factor, growth factors and VEGF (Nigam et al, 1994),
which could play a role in metastasis. It is important to explore the
expression level of their relevant factors for understanding
metastatic mechanisms.
Integrin a5, b1 is identified as one of the fibronectin (FN) recep-
tors. The loss, reduction or redistribution of a5,  b1 on cell
surfaces is implicated in detachment of adhering cells from ECM
timely for metastasis (Giancutti and Ruoslahti, 1990; Schreiner et
al, 1991; Albelda, 1993; Aznavoorian et al, 1993). E-cadherin is
Table 3 Abnormal chromosomes for MHCC97 cell lines
Chromosomes Markers
1(M1) Inv(1)(pter®q32::q42®q41::q43®qter)
1(M2) i(1)(q)
1,15(M4) t(1;15)(1qter®p13::15q12®qter)
4(M3) der(4)(pter®q35::?)
5,9 t(5qter®q11.2::9p13®qter)
7,9 t(7;9)(7qter®q11.1::9p11®qter)
13,14(8) t(13;14)(13qter®q14::14p112®qter)
11 (M10) del(11)(:p12®qter)
9,14 (M5) t(9;14)(9qter®q11::14p11®qter)
10, 14(6) t(10;14)(10qter®p11::14q112®qter)
17,?(M7) t(17;?)(17pter®q25::?)
20(M9) del(20)(pter®q12:)
X der(x;?)(xqter®xp11.1::?®xq11®xqter)
A B
D C
EF G
Figure 5 Immunohistochemical micrographs. Primary antibodies used are
the following: anti-c-Met (A, F), uPAR (B, G), integrin a5 (C), integrin b1 (D)
and E-cadherin (E) antibodies respectively. A–E were from intrahepatic
xenografts and pulmonary metastic lesions, and G, F from MHCC97 cells
grown on coverslips. Scale bar = 50 mm (A, B, E) and 25 mm (C, D, F, G)also an important adhesion molecule in inhibiting tumour metas-
tasis by connecting homophilic cells (Frixen et al, 1991). Its down-
regulation is implicated in metastasis of some malignant tumours
(Shimoyama and Hirohashi, 1991; Miyasaka, 1995). uPA is a
serine proteinase responsible for the degradation of ECM/BM and
activation of hepatocyte growth factor (HGF) (Daikuhara et al,
1992; Ellis et al, 1992; Blasi, 1993). Active uPA is found predom-
inantly at the cell surface, where it is retained by a high-affinity
receptor (uPAR). HGF is a pleiotropic effector of cells expressing
its receptor c-Met. HGF/Met signalling by stimulating growth and
migration of malignant cells enhances the tumorigenicity and
metastasis of cancer cells in vivo (Jeffers et al, 1996; Matsumoto
and Nukamura, 1996; Weidner et al, 1990). It can also elevate the
protein levels of both uPA and its receptor on cancer cells (Jeffers
et al, 1996). In addition, HGF/Met can also stimulate neo-angio-
genesis in vivo (Bussolino et al, 1992; Grant et al, 1993). VEGF
expressed in tumours is identified as responsible for the formation
of tumour vessels that not only allow for progression of the
primary tumours, but also facilitate cancer cells to access to the
tumour vessels (Fildler and Ellis, 1994; Koch et al, 1994).
The positive expressions of integrin a5, b1 indicated that the
cell line MHCC97 has acquired the ability to adhere to ECM/BM,
but its negative expression in metastaic lesions facilitates
MHCC97 cells to detach in a timely manner from ECM/BM for
metastasis. One of HGF effects is just contrary to one of E-
cadherin. The up-modulation of HGF/c-Met and down-modulation
of E-cadherin may result in the dispersion/scattering of MHCC97
cells, which may be favourable for metastasis. High expression of
uPAR would confer uPA on high active state, which promotes the
degradation of ECM/BM. It is not surprising that high expression
of VEGF is indispensable for MHCC97 cell metastasis. The
metastatic suppressor gene nm23 has been shown to promote the
growth of some tumours by cell proliferation following further
studies besides inhibiting metastasis (Igawa et al, 1994).
Our data indicated that the phenotype of cell line MHCC97 corre-
sponds to the characteristics of human HCC and retain some proper-
ties of original tumour, including AFP synthesis and metastatic
potential. The findings of factors associated with metastasis further
proved that cell line MHCC97 possesses the prerequisites for metas-
tasis. Integration of HBV into MHCC97 cells suggests that HBV
may participate in initiation and development of HCC.
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